Radical surgical resection after neoadjuvant targeted therapy in non-small cell lung cancer: a single-center retrospective study of 6 cases.
作者信息
Zhang Zhenyang, Lin Jiangbo, Peng Shuai, Lin Wenwei, Kang Mingqiang
机构信息
Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou 350000, China.
出版信息
J Thorac Dis. 2019 Jan;11(1):248-251. doi: 10.21037/jtd.2018.12.97.
Abstract
摘要
相似文献
1
Radical surgical resection after neoadjuvant targeted therapy in non-small cell lung cancer: a single-center retrospective study of 6 cases.非小细胞肺癌新辅助靶向治疗后根治性手术切除：一项6例单中心回顾性研究
J Thorac Dis. 2019 Jan;11(1):248-251. doi: 10.21037/jtd.2018.12.97.
2
Erratum to radical surgical resection after neoadjuvant targeted therapy in non-small cell lung cancer: a single-center retrospective study of 6 cases.非小细胞肺癌新辅助靶向治疗后根治性手术切除的勘误：6例单中心回顾性研究
J Thorac Dis. 2019 Jun;11(6):E88-E89. doi: 10.21037/jtd.2019.05.49.
3
Erlotinib as Neoadjuvant Therapy in Stage IIIA (N2) Mutation-Positive Non-Small Cell Lung Cancer: A Prospective, Single-Arm, Phase II Study.厄洛替尼作为 IIIA（N2）期突变阳性非小细胞肺癌新辅助治疗的前瞻性、单臂、Ⅱ期研究。
Oncologist. 2019 Feb;24(2):157-e64. doi: 10.1634/theoncologist.2018-0120. Epub 2018 Aug 29.
4
[Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].巩固性新辅助治疗或全新辅助治疗后低位直肠癌的保直肠手术：初步报告
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Mar 25;23(3):281-288. doi: 10.3760/cma.j.cn.441530-20200228-00096.
5
Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer: A propensity-matched analysis.新辅助或辅助化疗治疗 cT2-4N0-1 期非小细胞肺癌的结果：倾向评分匹配分析。
J Thorac Cardiovasc Surg. 2019 Feb;157(2):743-753.e3. doi: 10.1016/j.jtcvs.2018.09.098. Epub 2018 Oct 10.
6
A Novel Neoadjuvant Therapy for Operable Locally Invasive Non-Small-Cell Lung Cancer. Phase I Study of Neoadjuvant Stereotactic Body Radiotherapy. LINNEARRE I (NCT02433574).一种用于可手术的局部浸润性非小细胞肺癌的新型新辅助疗法。新辅助立体定向体部放射治疗的I期研究。LINNEARRE I（NCT02433574）。
Clin Lung Cancer. 2017 Jul;18(4):436-440.e1. doi: 10.1016/j.cllc.2017.01.007. Epub 2017 Jan 31.
7
Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non-small cell lung cancer.新辅助纳武利尤单抗治疗可切除非小细胞肺癌患者肺切除术后的初步结果。
J Thorac Cardiovasc Surg. 2019 Jul;158(1):269-276. doi: 10.1016/j.jtcvs.2018.11.124. Epub 2018 Dec 13.
8
[Surgical Procedures and Perioperative Management for Non-small Cell Lung Cancer Complicated with Left Atrial Tumor Thrombus].非小细胞肺癌合并左心房肿瘤血栓的外科手术及围手术期管理
Zhongguo Fei Ai Za Zhi. 2018 Jan 20;21(1):24-31. doi: 10.3779/j.issn.1009-3419.2018.01.04.
9
Retrospective study of surgical resection in the treatment of limited stage small cell lung cancer.手术切除治疗局限期小细胞肺癌的回顾性研究
Thorac Cancer. 2013 Nov;4(4):395-399. doi: 10.1111/1759-7714.12035.
10
Induction chemoradiotherapy facilitates radical resection of T4 non-small cell lung cancer invading the spine.诱导放化疗有助于侵犯脊柱的T4期非小细胞肺癌的根治性切除。
J Thorac Cardiovasc Surg. 2009 Feb;137(2):441-447.e1. doi: 10.1016/j.jtcvs.2008.09.035. Epub 2008 Dec 19.
引用本文的文献
1
Precision Surgery in NSCLC.非小细胞肺癌的精准手术
Cancers (Basel). 2023 Mar 3;15(5):1571. doi: 10.3390/cancers15051571.
2
Surgery after Induction Targeted Therapy and Immunotherapy for Lung Cancer.肺癌诱导靶向治疗和免疫治疗后的手术
Cancers (Basel). 2021 May 26;13(11):2603. doi: 10.3390/cancers13112603.
3
Neoadjuvant therapy for locally advanced non-small cell lung cancer: TKIs or immunotherapy?局部晚期非小细胞肺癌的新辅助治疗：酪氨酸激酶抑制剂还是免疫疗法？
J Thorac Dis. 2020 Mar;12(3):1151-1153. doi: 10.21037/jtd.2019.11.38.
4
IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy.IASLC 多学科推荐：新辅助治疗后肺癌切除标本的病理评估。
J Thorac Oncol. 2020 May;15(5):709-740. doi: 10.1016/j.jtho.2020.01.005. Epub 2020 Jan 28.
5
Neoadjuvant treatment with tyrosine kinase inhibitors in patients with resectable non-small cell lung cancer.酪氨酸激酶抑制剂用于可切除非小细胞肺癌患者的新辅助治疗。
J Thorac Dis. 2019 Oct;11(10):4092-4095. doi: 10.21037/jtd.2019.09.68.
6
Erratum to radical surgical resection after neoadjuvant targeted therapy in non-small cell lung cancer: a single-center retrospective study of 6 cases.非小细胞肺癌新辅助靶向治疗后根治性手术切除的勘误：6例单中心回顾性研究
J Thorac Dis. 2019 Jun;11(6):E88-E89. doi: 10.21037/jtd.2019.05.49.
本文引用的文献
1
Comparison of therapeutic effects of EGFR-tyrosine kinase inhibitors on 19Del and L858R mutations in advanced lung adenocarcinoma and effect on cellular immune function.比较表皮生长因子受体酪氨酸激酶抑制剂对晚期肺腺癌 19Del 和 L858R 突变的治疗效果及其对细胞免疫功能的影响。
Thorac Cancer. 2018 Feb;9(2):228-233. doi: 10.1111/1759-7714.12568. Epub 2017 Dec 9.
2
Long-term outcome of surgical resection for residual or regrown advanced non-small cell lung carcinomas following EGFR-TKI treatment: report of four cases.表皮生长因子受体酪氨酸激酶抑制剂（EGFR-TKI）治疗后残留或复发的晚期非小细胞肺癌手术切除的长期疗效：4例报告
Gen Thorac Cardiovasc Surg. 2016 Jul;64(7):429-33. doi: 10.1007/s11748-014-0508-5. Epub 2014 Dec 16.
3
Adenosquamous cell lung cancer successfully treated with gefitinib: A case report.吉非替尼成功治疗腺鳞癌型肺癌：一例报告
Mol Clin Oncol. 2014 Mar;2(2):282-284. doi: 10.3892/mco.2013.221. Epub 2013 Dec 9.
4
Surgical resection of locally advanced pulmonary adenocarcinoma after gefitinib therapy.吉非替尼治疗后局部晚期肺腺癌的手术切除。
Ann Thorac Surg. 2011 Jul;92(1):e11-2. doi: 10.1016/j.athoracsur.2011.02.021.
5
Surgical resection of lung adenocarcinoma without EGFR mutation after neoadjuvant gefitinib treatment.新辅助吉非替尼治疗后对无EGFR突变的肺腺癌进行手术切除。
Clin Respir J. 2010 Jul;4(3):192-3. doi: 10.1111/j.1752-699X.2009.00167.x.
6
A new concept of endoscopic lung cancer resection: Single-direction thoracoscopic lobectomy.一种新的内镜肺癌切除术概念：单向胸腔镜肺叶切除术。
Surg Oncol. 2010 Jun;19(2):e71-7. doi: 10.1016/j.suronc.2009.04.005. Epub 2009 Jun 4.
7
Surgical resection after gefitinib treatment in patients with lung adenocarcinoma harboring epidermal growth factor receptor gene mutation.表皮生长因子受体基因突变的肺腺癌患者接受吉非替尼治疗后的手术切除
Lung Cancer. 2007 Oct;58(1):149-55. doi: 10.1016/j.lungcan.2007.04.016. Epub 2007 Jun 4.
Zotero 插件